Peragine N, De Propris MS, Intoppa S, Milani ML, Mariglia P, Mauro FR, Raponi S, Soddu S, Cuneo A, Rigolin GM, Del Giudice I, Foà R, Guarini A. Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab. haematol [Internet]. 2021Apr.30 [cited 2024Nov.30];106(5):1500-3. Available from: https://haematologica.org/article/view/haematol.2020.262071